MetLife (MET) director Jeh C. Johnson granted 721 deferred shares as board pay

Rhea-AI Filing Summary

Johnson Jeh C. reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Jeh C. Johnson received 721 shares of common stock as a compensation award. The grant was valued at $71.17 per share and increased his directly held position to 8,850 shares.

A footnote explains that a portion of non-management director retainer fees is paid in MetLife common stock, and Johnson elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. This indicates the transaction is a routine equity-based board compensation event rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Johnson Jeh C.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	721	$71.17	$51K

Holdings After Transaction: Common Stock — 8,850 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 721 shares Grant valuation price: $71.17 per share Shares held after transaction: 8,850 shares

3 metrics

Shares granted 721 shares Common stock grant to director on 2026-04-01

Grant valuation price $71.17 per share Value used to report director stock award

Shares held after transaction 8,850 shares Director’s direct MetLife common stock holdings post-award

Key Terms

non-management director compensation, retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors

3 terms

non-management director compensation financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees"

retainer fees financial

"pay a portion of non-management director retainer fees in MetLife, Inc. common stock"

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Jeh C.

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		721	A	$71.17	8,850	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MET director Jeh C. Johnson report on this Form 4?

Jeh C. Johnson reported receiving 721 shares of MetLife Inc. common stock as a compensation-related award. The shares represent part of his non-management director retainer, paid in stock instead of cash under the company’s standard director compensation arrangements.

At what price was the MetLife (MET) director stock award valued?

The 721-share stock award to Jeh C. Johnson was valued at $71.17 per share. This price is used solely for reporting the grant’s value and does not indicate an open-market purchase or sale of MetLife stock by the director.

How many MetLife (MET) shares does Jeh C. Johnson hold after this transaction?

After the grant of 721 shares, Jeh C. Johnson directly holds 8,850 shares of MetLife common stock. This figure reflects his position following the reported compensation award and helps show the overall scale of his share ownership in the company.

Was the MetLife (MET) director’s Form 4 transaction an open-market buy or sell?

The transaction was not an open-market buy or sell. It was a grant or award of 721 MetLife common shares as part of non-management director compensation, reported under transaction code “A,” which covers grants, awards, or other acquisition events.

How were the MetLife (MET) director’s awarded shares treated under the company plan?

Jeh C. Johnson elected to defer receipt of his awarded shares under the MetLife Deferred Compensation Plan for Non-Management Directors. This means the stock-based portion of his director retainer is credited but actual delivery of shares is postponed according to plan terms.